Tissue fibrosis inhibitor in which biocompatible polymer is used
AssigneeKM Biologics Co., Ltd.
InventorsHideki SAGA, Minako INUI, Noriko OGURA
Life of this patent
Estimating the term…
Abstract
A problem to be solved by the present invention is to provide a fibrosis inhibitor that solves the problem of inhibiting fibrosis of an organ or tissue surface, and especially of inhibiting fibrosis of an epicardial surface. Furthermore, by inhibiting fibrosis, the present invention prevents or reduces subsequent development of adhesions to avoid organ or tissue damage during re-operation. Provided is a fibrosis inhibitor for inhibiting fibrosis of a tissue by fixing a biocompatible polymer to a tissue where it is desirable to inhibit fibrosis.
Claims13
A method of inhibiting tissue fibrosis comprising:
- applying a biocompatible polymer to one tissue in which a tissue fibrosis is to be inhibited,
- wherein the biocompatible polymer is fibrin.
A method of inhibiting tissue fibrosis comprising:
- applying a biocompatible polymer to one tissue in which a tissue fibrosis is to be inhibited, and suturing and fixing a cell scaffold material to a tissue defect site in another tissue,
- wherein the biocompatible polymer is fibrin.
A method of inhibiting tissue fibrosis comprising:
- applying a biocompatible polymer to one tissue in which a tissue fibrosis is to be inhibited and, suturing and fixing a pericardial substitute to a tissue defect site in another tissue,
- wherein the biocompatible polymer is fibrin.
A method of inhibiting a tissue adhesion, comprising:
- applying a biocompatible polymer to one tissue in which a tissue adhesion is to be inhibited, and suturing and fixing a cell scaffold material or a pericardial substitute to a tissue defect site in another tissue,
- wherein the biocompatible polymer is fibrin.
Dependencies are inferred from the claim text.